IN BRIEF: Incoming Indivior CEO Ciaffoni, other directors buy shares

Indivior PLC - Richmond, Virginia-based maker of medicines to treat substance use - Non-Executive ...

Alliance News 28 February, 2025 | 2:06PM
Email Form Facebook Twitter LinkedIn RSS

Indivior PLC - Richmond, Virginia-based maker of medicines to treat substance use - Non-Executive Director Joe Ciaffoni buys 56,000 shares at USD8.96, worth USD501,519, on Thursday. Indivior on Thursday named Ciaffoni as its next chief executive officer, replacing Mark Crossley. The handover is expected to be after Indivior's annual general meeting in May. Indivior said Crossley is stepping down "by mutual agreement" and "following a distinguished tenure" as CEO since 2020. Crossley joined the board in December, and the 56,000 shares are his first holding. Most recently, he was CEO of Nasdaq-listed Collegium Pharmaceutical Inc.

Ciaffoni is joined in buying Indivior shares on Thursday by Chair David Wheadon and non-executive directors Robert Schriesheim and Daniel Ninivaggi, who buy 10,000, 58,833 and 15,000 shares, respectively.

Current stock price: 675.50p, down 3.5% in London on Friday

12-month change: down 61%

By Tom Waite, Alliance News editor

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Indivior PLC Ordinary Share 666.50 GBX -4.79 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures